EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Serum Albumin and Post-Stroke Outcomes: Analysis of UK Regional Registry Data, Systematic Review, and Meta-Analysis

Rosa J Thuemmler, Tiberiu A Pana, Ben Carter iD, Ribeya Mahmood, Joao H Bettencourt-Silva, Anthony K Metcalf iD, Mamas A Mamas, John F Potter, Phyo K Myint iD

Nutrients · 14.05.2024 · 16 (10) · 1486

DOI: 10.3390/nu16101486 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Nutrients, online erschienen am 14.05.2024. Verfasst von Rosa J Thuemmler und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Applied Health Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen AB24 3FX, UK. Hauptthemen laut MEDLINE: Registries, Hospital Mortality, Serum Albumin. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Aberdeen Clinical Academic Pathway Programme, National Institute for Health Research (NIHR) Biomedical Research Centre at South London, Maudsley NHS Foundation Trust and King’s College London.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypoalbuminemia associates with poor acute ischemic stroke (AIS) outcomes. We hypothesised a non-linear relationship and aimed to systematically assess this association using prospective stroke data from the Norfolk and Norwich Stroke and TIA Register. Consecutive AIS patients aged ≥40 years admitted December 2003–December 2016 were included. Outcomes: In-hospital mortality, poor discharge, functional outcome (modified Rankin score 3–6), prolonged length of stay (PLoS) > 4 days, and long-term mortality. Restricted cubic spline regressions investigated the albumin–outcome relationship. We updated a systematic review (PubMed, Scopus, and Embase databases, January 2020–June 2023) and undertook a meta-analysis. A total of 9979 patients were included; mean age (standard deviation) = 78.3 (11.2) years; mean serum albumin 36.69 g/L (5.38). Compared to the cohort median, albumin < 37 g/L associated with up to two-fold higher long-term mortality (HRmax; 95% CI = 2.01; 1.61–2.49) and in-hospital mortality (RRmax; 95% CI = 1.48; 1.21–1.80). Albumin > 44 g/L associated with up to 12% higher long-term mortality (HRmax1.12; 1.06–1.19). Nine studies met our inclusion criteria totalling 23,597 patients. Low albumin associated with increased risk of long-term mortality (two studies; relative risk 1.57 (95% CI 1.11–2.22; I2 = 81.28)), as did low-normal albumin (RR 1.10 (95% CI 1.01–1.20; I2 = 0.00)). Strong evidence indicates increased long-term mortality in AIS patients with low or low-normal albumin on admission.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RegistriesHospital MortalitySerum AlbuminHumansAgedFemaleMaleUnited KingdomStrokeAged, 80 and overLength of StayHypoalbuminemiaIschemic StrokeMiddle Aged

Stichwörter der Autor:innen

albuminin-hospital outcomesischaemic strokelong-term mortalitynutritional

Substanzen

Serum Albumin

Autor:innen und Institutionen

  • Institute of Applied Health Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen AB24 3FX, UK.
  • Aberdeen Cardiovascular and Diabetes Centre, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB24 3FX, UK.
  • Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London WC2R 2LS, UK.
  • Norwich Medical School, University of East Anglia, Norwich NR4 7TJ, UK.
  • Stroke Research Group, Norfolk and Norwich University Hospital, Norwich NR4 7UY, UK.
  • Keele Cardiovascular Research Group, Centre for Prognosis Research, Institute for Primary Care and Health Sciences, Keele University, Stoke-on-Trent ST5 5BG, UK.

ORCID-Profile: Ben Carter, Anthony K Metcalf, Phyo K Myint

Förderung

  • Aberdeen Clinical Academic Pathway Programme
  • National Institute for Health Research (NIHR) Biomedical Research Centre at South London
  • Maudsley NHS Foundation Trust and King’s College London

Zitieren

APA

Thuemmler, R. J., Pana, T. A., Carter, B., Mahmood, R., Bettencourt-Silva, J. H., Metcalf, A. K., Mamas, M. A., Potter, J. F., & Myint, P. K. (2024). Serum Albumin and Post-Stroke Outcomes: Analysis of UK Regional Registry Data, Systematic Review, and Meta-Analysis. Nutrients, 16(10), 1486. https://doi.org/10.3390/nu16101486

Vancouver

Thuemmler RJ, Pana TA, Carter B, Mahmood R, Bettencourt-Silva JH, Metcalf AK, et al. Serum Albumin and Post-Stroke Outcomes: Analysis of UK Regional Registry Data, Systematic Review, and Meta-Analysis. Nutrients. 2024;16(10):1486. doi:10.3390/nu16101486

BibTeX
@article{Thuemmler2024,
  author = {Thuemmler, Rosa J and Pana, Tiberiu A and Carter, Ben and Mahmood, Ribeya and Bettencourt-Silva, Joao H and Metcalf, Anthony K and Mamas, Mamas A and Potter, John F and Myint, Phyo K},
  title = {Serum Albumin and Post-Stroke Outcomes: Analysis of UK Regional Registry Data, Systematic Review, and Meta-Analysis},
  journal = {Nutrients},
  year = {2024},
  volume = {16},
  number = {10},
  pages = {1486},
  doi = {10.3390/nu16101486}
}
Kostenlos starten →